- O'Donnell, Margaret R;
- Tallman, Martin S;
- Abboud, Camille N;
- Altman, Jessica K;
- Appelbaum, Frederick R;
- Arber, Daniel A;
- Attar, Eyal;
- Borate, Uma;
- Coutre, Steven E;
- Damon, Lloyd E;
- Lancet, Jeffrey;
- Maness, Lori J;
- Marcucci, Guido;
- Martin, Michael G;
- Millenson, Michael M;
- Moore, Joseph O;
- Ravandi, Farhad;
- Shami, Paul J;
- Smith, B Douglas;
- Stone, Richard M;
- Strickland, Stephen A;
- Wang, Eunice S;
- Gregory, Kristina M;
- Naganuma, Maoko
These NCCN Guidelines Insights summarize several key updates to the NCCN Guidelines for Acute Myeloid Leukemia and discuss the clinical evidence that support the recommendations. The updates described in this article focus on the acute promyelocytic leukemia (APL) section, featuring recommendations for additional induction/consolidation regimens in patients with low- or intermediate-risk APL, and providing guidance on maintenance strategies for APL.
